Jitka Fučíková

10.5k total citations · 2 hit papers
70 papers, 5.6k citations indexed

About

Jitka Fučíková is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jitka Fučíková has authored 70 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Immunology, 37 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Jitka Fučíková's work include Immunotherapy and Immune Responses (37 papers), Cancer Immunotherapy and Biomarkers (27 papers) and Immune Cell Function and Interaction (26 papers). Jitka Fučíková is often cited by papers focused on Immunotherapy and Immune Responses (37 papers), Cancer Immunotherapy and Biomarkers (27 papers) and Immune Cell Function and Interaction (26 papers). Jitka Fučíková collaborates with scholars based in Czechia, France and United States. Jitka Fučíková's co-authors include Radek Špíšek, Lorenzo Galluzzi, Guido Kroemer, Oliver Kepp, Laurence Zitvogel, Jiřina Bartůňková, Isabelle Cremer, Lenka Kašíková, Takahiro Yamazaki and Anna Fialová and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Jitka Fučíková

68 papers receiving 5.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Detection of immunogenic cell death and its relevance for cancer therapy

2020 756 citations Jitka Fučíková, Oliver Kepp et al. Cell Death and Disease profile →
Calreticulin and cancer

2020 299 citations Jitka Fučíková, Radek Špíšek et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jitka Fučíková Czechia	37	3.6k	2.8k	1.5k	767	637	70	5.6k
Radek Špíšek Czechia	45	4.8k 1.4×	3.3k 1.2×	1.9k 1.2×	829 1.1×	764 1.2×	134	7.6k
Aitziber Buqué United States	25	3.2k 0.9×	3.3k 1.2×	1.7k 1.2×	1.1k 1.4×	978 1.5×	51	6.2k
Mary Jo Turk United States	35	3.0k 0.8×	2.2k 0.8×	1.6k 1.1×	711 0.9×	372 0.6×	67	5.7k
Tetsuya Nakatsura Japan	37	1.8k 0.5×	2.1k 0.8×	2.3k 1.5×	575 0.7×	368 0.6×	139	5.0k
Antoine Tesnière France	20	4.7k 1.3×	3.2k 1.1×	2.1k 1.4×	1.1k 1.5×	651 1.0×	27	7.6k
Hua Liang China	29	4.1k 1.2×	4.1k 1.5×	2.2k 1.5×	510 0.7×	1.2k 2.0×	79	7.9k
Gabriele Niedermann Germany	34	1.6k 0.5×	1.9k 0.7×	2.0k 1.3×	504 0.7×	473 0.7×	81	4.7k
Eyad Elkord United Kingdom	41	3.9k 1.1×	4.3k 1.5×	2.2k 1.5×	443 0.6×	1.1k 1.7×	126	7.7k
María E. Rodríguez-Ruiz Spain	34	3.6k 1.0×	4.0k 1.4×	1.3k 0.9×	616 0.8×	880 1.4×	89	6.3k
W. Joost Lesterhuis Australia	39	4.2k 1.2×	3.5k 1.3×	1.9k 1.2×	665 0.9×	718 1.1×	86	6.7k

Countries citing papers authored by Jitka Fučíková

Since Specialization

Citations

This map shows the geographic impact of Jitka Fučíková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jitka Fučíková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jitka Fučíková more than expected).

Fields of papers citing papers by Jitka Fučíková

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jitka Fučíková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jitka Fučíková. The network helps show where Jitka Fučíková may publish in the future.

Co-authorship network of co-authors of Jitka Fučíková

This figure shows the co-authorship network connecting the top 25 collaborators of Jitka Fučíková. A scholar is included among the top collaborators of Jitka Fučíková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jitka Fučíková. Jitka Fučíková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liang, Ching-Yeu, Matteo Carrara, Ricardo Coelho, et al.. (2025). Ovarian cancer metastasis to the human omentum disrupts organ homeostasis and induces fundamental tissue reprogramming. Nature Communications. 17(1). 849–849.

Truxová, Iva, Jana Raková, Cyril Šálek, et al.. (2023). Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients. Cell Death and Disease. 14(3). 209–209. 15 indexed citations

Truxová, Iva, David Cibula, Radek Špíšek, & Jitka Fučíková. (2023). Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma. Journal for ImmunoTherapy of Cancer. 11(2). e005968–e005968. 43 indexed citations

Guilbaud, Emma, Vanessa Klapp, Iva Truxová, et al.. (2023). Type I interferon and cancer. Immunological Reviews. 321(1). 115–127. 55 indexed citations

Rob, Lukáš, David Cibula, Paweł Knapp, et al.. (2022). Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial. Journal for ImmunoTherapy of Cancer. 10(1). e003190–e003190. 31 indexed citations

Fučíková, Jitka, An Coosemans, Sandra Oršulić, et al.. (2021). Immunological configuration of ovarian carcinoma: features and impact on disease outcome. Journal for ImmunoTherapy of Cancer. 9(10). e002873–e002873. 33 indexed citations

Kašíková, Lenka, Michal Hensler, Iva Truxová, et al.. (2019). Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. Journal for ImmunoTherapy of Cancer. 7(1). 312–312. 60 indexed citations

Kašíková, Lenka, Iva Truxová, Isabelle Cremer, et al.. (2019). Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death. Methods in enzymology on CD-ROM/Methods in enzymology. 632. 15–25. 3 indexed citations

Truxová, Iva, Lenka Kašíková, Michal Hensler, et al.. (2018). Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients. Journal for ImmunoTherapy of Cancer. 6(1). 139–139. 144 indexed citations

10.

Bezu, Lucillia, Oliver Kepp, Giulia Cerrato, et al.. (2018). Trial watch: Peptide-based vaccines in anticancer therapy. OncoImmunology. 7(12). e1511506–e1511506. 120 indexed citations

11.

Fučíková, Jitka, Lenka Kašíková, Iva Truxová, et al.. (2017). Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer. Immunology Letters. 193. 25–34. 40 indexed citations

12.

Fučíková, Jitka, L. Jarolím, Michal Hensler, et al.. (2017). Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer. Cancer Immunology Immunotherapy. 67(1). 89–100. 35 indexed citations

13.

Vacchelli, Erika, Fernando Aranda, Norma Bloy, et al.. (2015). Trial Watch—Immunostimulation with cytokines in cancer therapy. OncoImmunology. 5(2). e1115942–e1115942. 44 indexed citations

14.

Bloy, Norma, Aitziber Buqué, Fernando Aranda, et al.. (2015). Trial watch: Naked and vectored DNA-based anticancer vaccines. OncoImmunology. 4(5). e1026531–e1026531. 32 indexed citations

15.

Pol, Jonathan, Aitziber Buqué, Fernando Aranda, et al.. (2015). Trial Watch—Oncolytic viruses and cancer therapy. OncoImmunology. 5(2). e1117740–e1117740. 92 indexed citations

16.

Mikyšková, Romana, Ivan Štěpánek, M Indrová, et al.. (2015). Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy. International Journal of Oncology. 48(3). 953–964. 31 indexed citations

17.

Buqué, Aitziber, Norma Bloy, Fernando Aranda, et al.. (2015). Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. OncoImmunology. 4(4). e1008814–e1008814. 103 indexed citations

18.

Bloy, Norma, Jonathan Pol, Fernando Aranda, et al.. (2014). Trial watch: Dendritic cell-based anticancer therapy. OncoImmunology. 3(11). e963424–e963424. 64 indexed citations

19.

Knights, Ashley, Jitka Fučíková, Anupama Pasam, Sandra Koernig, & Jonathan Cebon. (2012). Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy. Cancer Immunology Immunotherapy. 62(2). 321–335. 27 indexed citations

20.

Rožková, Daniela, Jitka Fučíková, Jan Lašťovička, et al.. (2009). FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer. Clinical Immunology. 131(1). 1–10. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact